Abstract
| Original language | English |
|---|---|
| Article number | e103345 |
| Number of pages | 20 |
| Journal | PLoS ONE |
| Volume | 9 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 28 Jul 2014 |
Fingerprint
Keywords
- people who inject drugs
- PWID
- hepatitis C
- HCV epidemiology
- Europe
Cite this
}
Hepatitis C virus infection epidemiology among people who inject drugs in Europe : a systematic review of data for scaling up treatment and prevention. / Ferri, Marica; Hatzakis, Angelos; Prins, Maria; Vickerman, Peter; Lazarus, Jeffrey V.; Hope, Vivian D.; Mathei, Catharina.
In: PLoS ONE , Vol. 9, No. 7, e103345, 28.07.2014.Research output: Contribution to journal › Article
TY - JOUR
T1 - Hepatitis C virus infection epidemiology among people who inject drugs in Europe
T2 - a systematic review of data for scaling up treatment and prevention
AU - Weissing, Lucas
AU - Ferri, Marica
AU - Hutchinson, Sharon
AU - Grady, Bart
AU - Kantzanou, Maria
AU - Sperle, Ida
AU - Cullen, Katelyn J.
AU - Hatzakis, Angelos
AU - Prins, Maria
AU - Vickerman, Peter
AU - Lazarus, Jeffrey V.
AU - Hope, Vivian D.
AU - Mathei, Catharina
N1 - HH: 07dec15: article published but document attached to record. updated as much as possible. Author is part of the EMCDDA DRID Group, see Acknowledgements section for Contributors listing. Date of acceptance: 29/06/2014
PY - 2014/7/28
Y1 - 2014/7/28
N2 - People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.
AB - People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.
KW - people who inject drugs
KW - PWID
KW - hepatitis C
KW - HCV epidemiology
KW - Europe
U2 - 10.1371/journal.pone.0103345
DO - 10.1371/journal.pone.0103345
M3 - Article
VL - 9
JO - PLoS ONE
JF - PLoS ONE
SN - 1932-6203
IS - 7
M1 - e103345
ER -